JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
94 hedge funds and large institutions have $669M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
Holders
94
Holding in Top 10
4
Calls
$21.4M
Puts
$1.58M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$7.69M | |
| 3 | +$6.54M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$4.51M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.42M |
Top Sellers
| 1 | -$6.35M | |
| 2 | -$3.73M | |
| 3 | -$3.66M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.51M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.34M |